March 14, 2026
Through her work on international guidelines, clinical research, and medical education, she continues to shape how diabetes care is delivered worldwide.
@media only screen and (max-width: 991px) {
.navbar1_menu-dropdown {
.navbar1_dropdown-toggle {
a.w-inline-block {
pointer-events: none !important;
}
}
.navbar1_dropdown-toggle.w--open {
a.w-inline-block {
pointer-events: auto !important;
}
}
}
}
.breadcrumb-container {
a {
color: #62a6e5;
letter-spacing: 1px;
text-transform: uppercase;
font-size: 12px;
font-weight: 500;
text-decoration: underline;
&:hover {
color: var(--brand-color--color-brand-2-400);
}
}
.breadcrumb-separator {
display: flex;
color: var(--brand-color--color-brand-1-400);
justify-content: center;
align-items: center;
font-size: 22px;
width: 1rem;
height: 1rem;
margin-left: .5rem;
margin-right: .5rem;
font-family: Manrope, sans-serif;
}
span {
letter-spacing: 1px;
text-transform: uppercase;
font-size: 12px;
color: var(--base-color-brand--white);
font-weight: 500;
text-decoration: none;
}
}
Congratulations to Chantal Mathieu, Recipient of the ATTD2026 Breakthrough Outcomes Award
Support us
Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund.
By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and reversing the onset of symptomatic type 1 diabetes. Every contribution moves us one step closer to breakthroughs that matter.